XTalks

FEBRUARY 27, 2024

Amtagvi Price Following the approval, Vogt revealed on a call that Amtagvi will be priced at a wholesale acquisition cost of $515,000 per patient. Addressing the high price tag, Iovance’s commercial chief Jim Ziegler said, “Payers have expressed their appreciation for the value proposition for Amtagvi.”

FDA Approval 52

FDA Approval Manufacturing In-Vivo Trials 52

Pharmaceutical Technology

JANUARY 27, 2023

Any refunds will consider the cheaper option between wholesale acquisition cost (WAC) or actual acquisition cost. Over the last few years, as price tags for drugs have continuously increased, the popularity of risk sharing agreements has been increasing at a rate of 24% annual average growth.

Manufacturing 130

Manufacturing Drugs Research Analyst FDA Approval 130

pharmaphorum

DECEMBER 2, 2020

This era, though, was also marked by two major failed acquisitions, which both courted controversy due to Pfizer’s intention to exploit tax loopholes. For all the latest Pfizer news follow pharmaphorum’s Pfizer tag. The post A history of Pfizer appeared first on.

Sales 128

Sales Production Drugs Marketing 128

pharmaphorum

FEBRUARY 26, 2021

However, it wasn’t until 1959 – 73 years and two major acquisitions later – that J&J developed its significant presence in the pharmaceutical industry. These two acquisitions enabled the company to gain a significant presence in the field of pharmaceutical medicines for the first time. Acquisitions post-Janssen.

Sales 121

Sales Production Pharma Companies Marketing 121

XTalks

SEPTEMBER 27, 2022

The record-breaking price tag of Skysona is not surprising for one-time gene therapies like it. The price tag reflects “the clinical benefit [it] provides as an urgently needed treatment option to slow the progression of neurologic dysfunction in children impacted by progressive, irreversible and fatal rare disease,” Obenshain added.

FDA Approval 52

FDA Approval Gene Therapy Drugs Gene 52

XTalks

MARCH 22, 2023

Pharmaceutical Industry Mergers & Acquisitions The pharmaceutical industry has been no stranger to change over the past 20 years, with high-profile, high-value mergers and acquisitions changing the landscape considerably. In 2019, BMS acquired Celgene in a $74 billion deal.

Life Science 97

Life Science Drugs FDA Approval Vaccination 97

Delveinsight

DECEMBER 3, 2020

The acquisition has been concluded but is anticipated to have little influence on net revenues for the year, according to the company. It has been speculated that modifications to the epigenome drive cell ageing, especially a process known as DNA methylation, by which methyl groups are tagged onto DNA.

Gene Therapy 52

Gene Therapy Gene Antibody Research 52

XTalks

JANUARY 19, 2024

Over the last year, there have been new acquisitions, launches and deals for novel radiotherapeutics and newly created peptide-radioisotope drug conjugates. There have been more than $1.7 billion influx into radiopharmaceuticals which underscores the potential and robust growth in this therapeutic area.

DNA 66

DNA Radiology FDA Approval Development 66

The Pharma Data

MAY 4, 2021

2) Adjusted income and its components and Adjusted diluted EPS are defined as reported U.S. GAAP net income and its components and diluted EPS (1). (3) The information contained on our website or any third-party website is not incorporated by reference into this earnings release. View source version on businesswire.com : [link]. Source: Pfizer Inc.

Vaccination 40

Vaccination Vaccine Production Sales 40